-
In what could be a boon for infection surveillance and treatment programs, the Food and Drug Administration (FDA) has approved a new rapid test for methicillin-resistant Staphylococcus aureus (MRSA) that can identify the bug in two hours.
-
-
This is a three-part series on using financial data to demonstrate the value of occupational health programs. This month, we report on how to demonstrate cost savings to your employer and give a checklist of data you should present.
-
Below are key pieces of data you should include when presenting senior management with a cost/benefit analysis, recommends Tamara Y. Blow, manager of occupational health services at Philip Morris USA:
-
Obtaining source patient consent for HIV testing after a bloodborne pathogen exposure might slowly be getting easier. Some states have responded to the Centers for Disease Control and Prevention (CDC) recommendation to make HIV testing a routine part of health care.
-
There are about 19 million new cases of sexually transmitted infections (STIs) annually in the United States, "and they don't just happen to people who are promiscuous or reckless," says Fred Wyand, media and communications manager for the American Social Health Association (ASHA) in Research Triangle Park, NC.
-
Haven already battled flu this year with a mismatched vaccine, public health officials have taken the unprecedented step of changing all three influenza strains in the vaccine under development for the 2008-2009 season.
-
Despite a slow beginning, the U.S. Department of Veterans Affairs' implementation of Cooperative Research and Development Agreements (CRADAs) for clinical trials could prove to be a model for the clinical research (CR) industry.
-
From the moment Southeast Regional Research Group of Columbus, GA, starts the clinical trial process to the study's close-out, investigators and clinical trial (CT) staff follow best practices.
-
One of the major changes the clinical trial (CT) industry has undergone involves study design, according to a researcher who has been in the business for more than three decades.
